Dr. M Blatstein's Blog, Medical, Sentence Mitigation

Fourth Temporary Telemedicine Extension Rule: Documentation Is Key

STILL, TELEMEDICINE AND HEALTHCARE ARE THE DOJ’S #1 TARGET.

*

A clearer summary that preserves the substance:

Fourth Temporary Telemedicine Rule (DEA & HHS)
The DEA and HHS have issued a Fourth Temporary Telemedicine Rule extending COVID-era telehealth flexibilities for prescribing controlled substances through December 31, 2026.

Key Points

    • Agencies: DEA and HHS

    • Effective: January 1, 2026

    • Expires: December 31, 2026

    • Purpose: Continues temporary telemedicine flexibilities for prescribing certain controlled substances first authorized during the COVID-19 public health emergency.

Bottom Line:

The rule provides continuity for patients and providers by allowing remote consultations and prescribing of qualifying controlled medications to continue for an additional year beyond prior extensions.

Details Page 6.

*

Fourth Temporary Telemedicine RuleDownload

m

 

DEA-HHS Use of Telemedicine While ProvidingDownload

d

 

DEA The Controlled Substances ActDownload